TELA Bio, Inc.
TELA
$1.69
-$0.05-2.87%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.06% | 4.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.06% | 4.94% | |||
| Cost of Revenue | 1.42% | -6.63% | |||
| Gross Profit | 12.64% | 11.41% | |||
| SG&A Expenses | 2.64% | 16.52% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.99% | 11.49% | |||
| Operating Income | 13.28% | -25.35% | |||
| Income Before Tax | 11.79% | -19.89% | |||
| Income Tax Expenses | -36.54% | 136.11% | |||
| Earnings from Continuing Operations | 11.91% | -22.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.91% | -22.33% | |||
| EBIT | 13.28% | -25.35% | |||
| EBITDA | 13.66% | -26.17% | |||
| EPS Basic | 12.10% | -8.27% | |||
| Normalized Basic EPS | 11.95% | -6.10% | |||
| EPS Diluted | 12.10% | -8.27% | |||
| Normalized Diluted EPS | 11.95% | -6.10% | |||
| Average Basic Shares Outstanding | 0.22% | 12.96% | |||
| Average Diluted Shares Outstanding | 0.22% | 12.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||